- Cello Health hiked its dividend after annual pre-tax profits jumped sharply amid a 'strong' performance from its Cello Health segment.

For the year ended 31 December 2018, reported profit before tax up 44.7% to £8.4m and revenue increased by 2.3% to £104.8m.

The Cello Health division generated constant currency like-for-like net revenue growth of 4.3% for the year, driven by strong performance across its insight, consulting and communications operations, the company said.

The company proposed an increase in the final dividend per share of 12.2% to 2.75p, If approved by shareholders, this would take the total dividend to 3.85p, up 10% from 3.50p last year, the company said.

'In 2019, we will continue to invest in new initiatives that enhance our differentiated services. We will continue to focus on growing our presence in the US and leveraging Signal's digital capability into the healthcare sector,' the company said.

'The Group has begun 2019 with good levels of forward bookings and has already secured a good number of new business wins. Accordingly, the Board is confident of a strong performance for 2019 in line with current market expectations.'

At 8:38am: [LON:CLL] Cello Group PLC share price was +1p at 124.5p

Story provided by